APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dermatological Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchDermatological Medicine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Medicine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Dermatological Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Medicine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Medicine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Dermatological Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dermatological Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dermatological Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dermatological Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dermatological Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dermatological Medicine include Chongqing Huapont Pharm Co., China National Pharmaceutical Group, Xiuzheng Pharmaceutical Group, Johnson and Johnson, Merck, Harbin Letai, Pfizer, China Resources Pharmaceutical Group and Hebei Xinglong Xili Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dermatological Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dermatological Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dermatological Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dermatological Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Dermatological Medicine Segment by Company

Chongqing Huapont Pharm Co.

China National Pharmaceutical Group

Xiuzheng Pharmaceutical Group

Johnson and Johnson

Merck

Harbin Letai

Pfizer

China Resources Pharmaceutical Group

Hebei Xinglong Xili Pharmaceutical

GSK

Bayer

AbbVie

Taisho Pharmaceutical

Reckitt Benckiser

Perrigo

LEO Pharma

Ikeda Mohando

DermaPharm A/S

Bright Future Pharmaceutical

Dermatological Medicine Segment by Type

Calcineurin Inhibitors

Anti-acne

Anti-infectives

Corticosteroids

Retinoids

Others

Dermatological Medicine Segment by Application

Psoriasis

Alopecia

Atopic Dermatitis

Herpes

Rosacea

Others

Dermatological Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dermatological Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatological Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dermatological Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dermatological Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dermatological Medicine Industry Trends Table 2. Dermatological Medicine Industry Drivers Table 3. Dermatological Medicine Industry Opportunities and Challenges Table 4. Dermatological Medicine Industry Restraints Table 5. Global Dermatological Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dermatological Medicine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dermatological Medicine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dermatological Medicine Sales Market Share by Manufacturers Table 9. Global Dermatological Medicine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dermatological Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dermatological Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dermatological Medicine Manufacturers, Product Type & Application Table 13. Global Dermatological Medicine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dermatological Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Calcineurin Inhibitors Table 17. Major Manufacturers of Anti-acne Table 18. Major Manufacturers of Anti-infectives Table 19. Major Manufacturers of Corticosteroids Table 20. Major Manufacturers of Retinoids Table 21. Major Manufacturers of Others Table 22. Global Dermatological Medicine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Dermatological Medicine Sales by Type (2021-2026) & (K Units) Table 24. Global Dermatological Medicine Sales by Type (2027-2032) & (K Units) Table 25. Global Dermatological Medicine Sales Market Share by Type (2021-2026) Table 26. Global Dermatological Medicine Sales Market Share by Type (2027-2032) Table 27. Global Dermatological Medicine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Dermatological Medicine Revenue by Type (2021-2026) & (K Units) Table 29. Global Dermatological Medicine Revenue by Type (2027-2032) & (K Units) Table 30. Global Dermatological Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Dermatological Medicine Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Psoriasis Table 33. Major Manufacturers of Alopecia Table 34. Major Manufacturers of Atopic Dermatitis Table 35. Major Manufacturers of Herpes Table 36. Major Manufacturers of Rosacea Table 37. Major Manufacturers of Others Table 38. Global Dermatological Medicine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dermatological Medicine Sales by Application (2021-2026) & (K Units) Table 40. Global Dermatological Medicine Sales by Application (2027-2032) & (K Units) Table 41. Global Dermatological Medicine Sales Market Share by Application (2021-2026) Table 42. Global Dermatological Medicine Sales Market Share by Application (2027-2032) Table 43. Global Dermatological Medicine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Dermatological Medicine Revenue by Application (2021-2026) & (K Units) Table 45. Global Dermatological Medicine Revenue by Application (2027-2032) & (K Units) Table 46. Global Dermatological Medicine Revenue Market Share by Application (2021-2026) Table 47. Global Dermatological Medicine Revenue Market Share by Application (2027-2032) Table 48. Global Dermatological Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Dermatological Medicine Sales by Region (2021-2026) & (K Units) Table 50. Global Dermatological Medicine Sales Market Share by Region (2021-2026) Table 51. Global Dermatological Medicine Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Dermatological Medicine Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 55. North America Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 56. Europe Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 58. Europe Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Dermatological Medicine Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Dermatological Medicine Sales by Country (2027-2032) & (K Units) Table 65. Global Dermatological Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Dermatological Medicine Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Dermatological Medicine Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Dermatological Medicine Revenue Market Share by Region (2021-2026) Table 69. Global Dermatological Medicine Revenue Market Share by Region (2027-2032) Table 70. Chongqing Huapont Pharm Co. Company Information Table 71. Chongqing Huapont Pharm Co. Business Overview Table 72. Chongqing Huapont Pharm Co. Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio Table 74. Chongqing Huapont Pharm Co. Recent Development Table 75. China National Pharmaceutical Group Company Information Table 76. China National Pharmaceutical Group Business Overview Table 77. China National Pharmaceutical Group Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. China National Pharmaceutical Group Dermatological Medicine Product Portfolio Table 79. China National Pharmaceutical Group Recent Development Table 80. Xiuzheng Pharmaceutical Group Company Information Table 81. Xiuzheng Pharmaceutical Group Business Overview Table 82. Xiuzheng Pharmaceutical Group Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio Table 84. Xiuzheng Pharmaceutical Group Recent Development Table 85. Johnson and Johnson Company Information Table 86. Johnson and Johnson Business Overview Table 87. Johnson and Johnson Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Johnson and Johnson Dermatological Medicine Product Portfolio Table 89. Johnson and Johnson Recent Development Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Merck Dermatological Medicine Product Portfolio Table 94. Merck Recent Development Table 95. Harbin Letai Company Information Table 96. Harbin Letai Business Overview Table 97. Harbin Letai Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Harbin Letai Dermatological Medicine Product Portfolio Table 99. Harbin Letai Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Pfizer Dermatological Medicine Product Portfolio Table 104. Pfizer Recent Development Table 105. China Resources Pharmaceutical Group Company Information Table 106. China Resources Pharmaceutical Group Business Overview Table 107. China Resources Pharmaceutical Group Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio Table 109. China Resources Pharmaceutical Group Recent Development Table 110. Hebei Xinglong Xili Pharmaceutical Company Information Table 111. Hebei Xinglong Xili Pharmaceutical Business Overview Table 112. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio Table 114. Hebei Xinglong Xili Pharmaceutical Recent Development Table 115. GSK Company Information Table 116. GSK Business Overview Table 117. GSK Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. GSK Dermatological Medicine Product Portfolio Table 119. GSK Recent Development Table 120. Bayer Company Information Table 121. Bayer Business Overview Table 122. Bayer Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bayer Dermatological Medicine Product Portfolio Table 124. Bayer Recent Development Table 125. AbbVie Company Information Table 126. AbbVie Business Overview Table 127. AbbVie Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. AbbVie Dermatological Medicine Product Portfolio Table 129. AbbVie Recent Development Table 130. Taisho Pharmaceutical Company Information Table 131. Taisho Pharmaceutical Business Overview Table 132. Taisho Pharmaceutical Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Taisho Pharmaceutical Dermatological Medicine Product Portfolio Table 134. Taisho Pharmaceutical Recent Development Table 135. Reckitt Benckiser Company Information Table 136. Reckitt Benckiser Business Overview Table 137. Reckitt Benckiser Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Reckitt Benckiser Dermatological Medicine Product Portfolio Table 139. Reckitt Benckiser Recent Development Table 140. Perrigo Company Information Table 141. Perrigo Business Overview Table 142. Perrigo Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Perrigo Dermatological Medicine Product Portfolio Table 144. Perrigo Recent Development Table 145. LEO Pharma Company Information Table 146. LEO Pharma Business Overview Table 147. LEO Pharma Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. LEO Pharma Dermatological Medicine Product Portfolio Table 149. LEO Pharma Recent Development Table 150. Ikeda Mohando Company Information Table 151. Ikeda Mohando Business Overview Table 152. Ikeda Mohando Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Ikeda Mohando Dermatological Medicine Product Portfolio Table 154. Ikeda Mohando Recent Development Table 155. DermaPharm A/S Company Information Table 156. DermaPharm A/S Business Overview Table 157. DermaPharm A/S Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. DermaPharm A/S Dermatological Medicine Product Portfolio Table 159. DermaPharm A/S Recent Development Table 160. Bright Future Pharmaceutical Company Information Table 161. Bright Future Pharmaceutical Business Overview Table 162. Bright Future Pharmaceutical Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Bright Future Pharmaceutical Dermatological Medicine Product Portfolio Table 164. Bright Future Pharmaceutical Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Dermatological Medicine Distributors List Table 168. Dermatological Medicine Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Dermatological Medicine Product Image Figure 2. Global Dermatological Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatological Medicine Sales (2021-2032) & (K Units) Figure 5. Global Dermatological Medicine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dermatological Medicine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Calcineurin Inhibitors Image Figure 9. Anti-acne Image Figure 10. Anti-infectives Image Figure 11. Corticosteroids Image Figure 12. Retinoids Image Figure 13. Others Image Figure 14. Global Dermatological Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Dermatological Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Dermatological Medicine Sales Market Share by Type (2021-2032) Figure 17. Global Dermatological Medicine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Dermatological Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Dermatological Medicine Revenue Market Share by Type (2021-2032) Figure 20. Psoriasis Image Figure 21. Alopecia Image Figure 22. Atopic Dermatitis Image Figure 23. Herpes Image Figure 24. Rosacea Image Figure 25. Others Image Figure 26. Global Dermatological Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Dermatological Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Dermatological Medicine Sales Market Share by Application (2021-2032) Figure 29. Global Dermatological Medicine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Dermatological Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Dermatological Medicine Revenue Market Share by Application (2021-2032) Figure 32. North America Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 34. U.S. Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 39. Germany Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 46. China Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Dermatological Medicine Sales Market Share by Country (2021-2032) Figure 54. Brazil Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Dermatological Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Dermatological Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Dermatological Medicine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Dermatological Medicine Revenue (2021-2032) & (US$ Million) Figure 65. North America Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Dermatological Medicine Revenue (2021-2032) & (US$ Million) Figure 67. Europe Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Dermatological Medicine Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Dermatological Medicine Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Dermatological Medicine Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Dermatological Medicine Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Calcineurin Inhibitors
  • Anti-acne
  • Anti-infectives
  • Corticosteroids
  • Retinoids
  • Others
Applications
  • Psoriasis
  • Alopecia
  • Atopic Dermatitis
  • Herpes
  • Rosacea
  • Others
Companies covered
  • Chongqing Huapont Pharm Co.
  • China National Pharmaceutical Group
  • Xiuzheng Pharmaceutical Group
  • Johnson and Johnson
  • Merck
  • Harbin Letai
  • Pfizer
  • China Resources Pharmaceutical Group
  • Hebei Xinglong Xili Pharmaceutical
  • GSK
  • Bayer
  • AbbVie
  • Taisho Pharmaceutical
  • Reckitt Benckiser
  • Perrigo
  • LEO Pharma
  • Ikeda Mohando
  • DermaPharm A/S
  • Bright Future Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dermatological Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dermatological Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dermatological Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dermatological Medicine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dermatological Medicine Market Dynamics
  1. 2.1 Dermatological Medicine Industry Trends
  2. 2.2 Dermatological Medicine Industry Drivers
  3. 2.3 Dermatological Medicine Industry Opportunities and Challenges
  4. 2.4 Dermatological Medicine Industry Restraints
3 Dermatological Medicine Market by Manufacturers
  1. 3.1 Global Dermatological Medicine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dermatological Medicine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dermatological Medicine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dermatological Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatological Medicine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dermatological Medicine Manufacturers, Product Type & Application
  7. 3.7 Global Dermatological Medicine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatological Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatological Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatological Medicine Tier 1, Tier 2, and Tier 3
4 Dermatological Medicine Market by Type
  1. 4.1 Dermatological Medicine Type Introduction
  2. 4.1.1 Calcineurin Inhibitors
  3. 4.1.2 Anti-acne
  4. 4.1.3 Anti-infectives
  5. 4.1.4 Corticosteroids
  6. 4.1.5 Retinoids
  7. 4.1.6 Others
  8. 4.2 Global Dermatological Medicine Sales by Type
  9. 4.2.1 Global Dermatological Medicine Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Dermatological Medicine Sales by Type (2021-2032)
  11. 4.2.3 Global Dermatological Medicine Sales Market Share by Type (2021-2032)
  12. 4.3 Global Dermatological Medicine Revenue by Type
  13. 4.3.1 Global Dermatological Medicine Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Dermatological Medicine Revenue by Type (2021-2032)
  15. 4.3.3 Global Dermatological Medicine Revenue Market Share by Type (2021-2032)
5 Dermatological Medicine Market by Application
  1. 5.1 Dermatological Medicine Application Introduction
  2. 5.1.1 Psoriasis
  3. 5.1.2 Alopecia
  4. 5.1.3 Atopic Dermatitis
  5. 5.1.4 Herpes
  6. 5.1.5 Rosacea
  7. 5.1.6 Others
  8. 5.2 Global Dermatological Medicine Sales by Application
  9. 5.2.1 Global Dermatological Medicine Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Dermatological Medicine Sales by Application (2021-2032)
  11. 5.2.3 Global Dermatological Medicine Sales Market Share by Application (2021-2032)
  12. 5.3 Global Dermatological Medicine Revenue by Application
  13. 5.3.1 Global Dermatological Medicine Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Dermatological Medicine Revenue by Application (2021-2032)
  15. 5.3.3 Global Dermatological Medicine Revenue Market Share by Application (2021-2032)
6 Global Dermatological Medicine Sales by Region
  1. 6.1 Global Dermatological Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dermatological Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Dermatological Medicine Sales by Region (2021-2026)
  4. 6.2.2 Global Dermatological Medicine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dermatological Medicine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dermatological Medicine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dermatological Medicine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dermatological Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dermatological Medicine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dermatological Medicine Revenue by Region
  1. 7.1 Global Dermatological Medicine Revenue by Region
  2. 7.1.1 Global Dermatological Medicine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dermatological Medicine Revenue by Region (2021-2026)
  4. 7.1.3 Global Dermatological Medicine Revenue by Region (2027-2032)
  5. 7.1.4 Global Dermatological Medicine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dermatological Medicine Revenue (2021-2032)
  8. 7.2.2 North America Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dermatological Medicine Revenue (2021-2032)
  11. 7.3.2 Europe Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dermatological Medicine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dermatological Medicine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dermatological Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Huapont Pharm Co.
  2. 8.1.1 Chongqing Huapont Pharm Co. Company Information
  3. 8.1.2 Chongqing Huapont Pharm Co. Business Overview
  4. 8.1.3 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Huapont Pharm Co. Dermatological Medicine Product Portfolio
  6. 8.1.5 Chongqing Huapont Pharm Co. Recent Developments
  7. 8.2 China National Pharmaceutical Group
  8. 8.2.1 China National Pharmaceutical Group Company Information
  9. 8.2.2 China National Pharmaceutical Group Business Overview
  10. 8.2.3 China National Pharmaceutical Group Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China National Pharmaceutical Group Dermatological Medicine Product Portfolio
  12. 8.2.5 China National Pharmaceutical Group Recent Developments
  13. 8.3 Xiuzheng Pharmaceutical Group
  14. 8.3.1 Xiuzheng Pharmaceutical Group Company Information
  15. 8.3.2 Xiuzheng Pharmaceutical Group Business Overview
  16. 8.3.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Product Portfolio
  18. 8.3.5 Xiuzheng Pharmaceutical Group Recent Developments
  19. 8.4 Johnson and Johnson
  20. 8.4.1 Johnson and Johnson Company Information
  21. 8.4.2 Johnson and Johnson Business Overview
  22. 8.4.3 Johnson and Johnson Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson and Johnson Dermatological Medicine Product Portfolio
  24. 8.4.5 Johnson and Johnson Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Dermatological Medicine Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Harbin Letai
  32. 8.6.1 Harbin Letai Company Information
  33. 8.6.2 Harbin Letai Business Overview
  34. 8.6.3 Harbin Letai Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Letai Dermatological Medicine Product Portfolio
  36. 8.6.5 Harbin Letai Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Dermatological Medicine Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 China Resources Pharmaceutical Group
  44. 8.8.1 China Resources Pharmaceutical Group Company Information
  45. 8.8.2 China Resources Pharmaceutical Group Business Overview
  46. 8.8.3 China Resources Pharmaceutical Group Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 China Resources Pharmaceutical Group Dermatological Medicine Product Portfolio
  48. 8.8.5 China Resources Pharmaceutical Group Recent Developments
  49. 8.9 Hebei Xinglong Xili Pharmaceutical
  50. 8.9.1 Hebei Xinglong Xili Pharmaceutical Company Information
  51. 8.9.2 Hebei Xinglong Xili Pharmaceutical Business Overview
  52. 8.9.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product Portfolio
  54. 8.9.5 Hebei Xinglong Xili Pharmaceutical Recent Developments
  55. 8.10 GSK
  56. 8.10.1 GSK Company Information
  57. 8.10.2 GSK Business Overview
  58. 8.10.3 GSK Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GSK Dermatological Medicine Product Portfolio
  60. 8.10.5 GSK Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Dermatological Medicine Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 AbbVie
  68. 8.12.1 AbbVie Company Information
  69. 8.12.2 AbbVie Business Overview
  70. 8.12.3 AbbVie Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AbbVie Dermatological Medicine Product Portfolio
  72. 8.12.5 AbbVie Recent Developments
  73. 8.13 Taisho Pharmaceutical
  74. 8.13.1 Taisho Pharmaceutical Company Information
  75. 8.13.2 Taisho Pharmaceutical Business Overview
  76. 8.13.3 Taisho Pharmaceutical Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Taisho Pharmaceutical Dermatological Medicine Product Portfolio
  78. 8.13.5 Taisho Pharmaceutical Recent Developments
  79. 8.14 Reckitt Benckiser
  80. 8.14.1 Reckitt Benckiser Company Information
  81. 8.14.2 Reckitt Benckiser Business Overview
  82. 8.14.3 Reckitt Benckiser Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Reckitt Benckiser Dermatological Medicine Product Portfolio
  84. 8.14.5 Reckitt Benckiser Recent Developments
  85. 8.15 Perrigo
  86. 8.15.1 Perrigo Company Information
  87. 8.15.2 Perrigo Business Overview
  88. 8.15.3 Perrigo Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Perrigo Dermatological Medicine Product Portfolio
  90. 8.15.5 Perrigo Recent Developments
  91. 8.16 LEO Pharma
  92. 8.16.1 LEO Pharma Company Information
  93. 8.16.2 LEO Pharma Business Overview
  94. 8.16.3 LEO Pharma Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 LEO Pharma Dermatological Medicine Product Portfolio
  96. 8.16.5 LEO Pharma Recent Developments
  97. 8.17 Ikeda Mohando
  98. 8.17.1 Ikeda Mohando Company Information
  99. 8.17.2 Ikeda Mohando Business Overview
  100. 8.17.3 Ikeda Mohando Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ikeda Mohando Dermatological Medicine Product Portfolio
  102. 8.17.5 Ikeda Mohando Recent Developments
  103. 8.18 DermaPharm A/S
  104. 8.18.1 DermaPharm A/S Company Information
  105. 8.18.2 DermaPharm A/S Business Overview
  106. 8.18.3 DermaPharm A/S Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 DermaPharm A/S Dermatological Medicine Product Portfolio
  108. 8.18.5 DermaPharm A/S Recent Developments
  109. 8.19 Bright Future Pharmaceutical
  110. 8.19.1 Bright Future Pharmaceutical Company Information
  111. 8.19.2 Bright Future Pharmaceutical Business Overview
  112. 8.19.3 Bright Future Pharmaceutical Dermatological Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bright Future Pharmaceutical Dermatological Medicine Product Portfolio
  114. 8.19.5 Bright Future Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dermatological Medicine Value Chain Analysis
  2. 9.1.1 Dermatological Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dermatological Medicine Production Mode & Process
  6. 9.2 Dermatological Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dermatological Medicine Distributors
  9. 9.2.3 Dermatological Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst